Literature DB >> 25993137

The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big Data.

Edward S Kim1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25993137     DOI： 10.14694/EdBook_AM.2015.35.22

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN： 1548-8748


× No keyword cloud information.
  1 in total

1.  Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.

Authors:  Manojkumar Bupathi; Joud Hajjar; Stacie Bean; Siqing Fu; David Hong; Daniel Karp; Bettzy Stephen; Kenneth Hess; Funda Meric-Bernstam; Aung Naing
Journal:  Invest New Drugs       Date:  2016-09-29       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.